roxy_nash said:DanielChem_CHI said: ...regarding the discontinuation data for cost and coverage...
Telehealth prescriber review for cost and coverage: I've used 2 different telehealth platforms to get my GLP-1 prescription. Comparison:
| Feature | Platform A | Platform B | Platform C |
|---|---|---|---|
| Initial Consult | $75 | $85 | $0 |
| Monthly Follow-up | $35 | Included | $60 |
| Prescription Speed | Same day | 24-48 hours | Same day |
| Lab Monitoring | Required | Optional | Required |
I settled on the one that required labs — it shows they care about safety, not just prescribing volume.
Dr.PulmRoch said:My insurance denied my PA related to cost and coverage.
This answered a question I did not know how to ask. Adding it to my notes with a link back to this thread.
roxy_nash said:DanielChem_CHI said: ...regarding the discontinuation data for cost and coverage...
Financial impact of cost and coverage weight loss beyond medication cost:
- Groceries: SAVED $220/month (eating less)
- Restaurants: SAVED $150/month (fewer meals out)
- Alcohol: SAVED $100/month (stopped drinking)
- Life insurance: Premium REDUCED by $30/month (lower BMI)
- Copays: SAVED $60/month (fewer BP/cholesterol meds)
Net impact after medication cost: approximately BREAKING EVEN. The medication pays for itself through reduced food spending and healthcare costs. This surprised me.
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGL Biochem (Shanghai) Ltd. — Direct Manufacturer
Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemRunnerRach said:The list price and the price I actually pay differ by a factor of six depending on which of four routes I use, and none of that is transparent from…
RunnerRach said:...my insurance denied cost and coverage coverage because...
Insurance denial is the single biggest barrier to GLP-1 access. Let me share the appeal framework that worked for me and several community members:
- Document medical necessity (BMI, comorbidities, failed alternatives)
- Reference clinical practice guidelines (AGA, AACE, Endocrine Society)
- Cite cost-effectiveness data (preventing diabetes/surgery saves money long-term)
- Request peer-to-peer review between your doctor and the plan's medical director
- File external appeal with your state insurance department if internal appeal fails
Don't accept the first denial. The appeal process exists for a reason.
Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.